Latigo Biotherapeutics, Inc. · NASDAQ:LTGO

Sanofi converted 672,778 Latigo Biotherapeutics, Inc. shares (Form 4)

Traded Aug 10, 2026 · Filed Aug 12, 2026

On Aug 10, 2026, Sanofi (10% owner) converted 672,778 Latigo Biotherapeutics, Inc. shares, leaving 672,788 shares. Filed Aug 12, 2026 (Form 4).

Converted
672,778 shares
Holding after
672,788 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 10, 2026Common StockConversion494,800494,800Indirect
Aug 10, 2026Common StockConversion177,978672,788Indirect

Source

View original at SEC

Related